Top Banner

of 5

Betamethasone Reduces Postoperative Pain and.15

Feb 19, 2018

Download

Documents

Nur Atika
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 7/23/2019 Betamethasone Reduces Postoperative Pain and.15

    1/5

    Betamethasone Reduces Postoperative Pain and Nausea

    After Ambulatory Surgery

    Vidar Aasboe,

    MD*,

    Johan C. Raeder,

    PhD, MD*,

    and Bjarne Groegaard,

    rhD, MDt

    Departments of *Anesthesia and tsurgery, Ullevaal University Hospital, Oslo, Norway

    The aims of this study were to evaluate the effects of a

    single-dose glucocort icoid on the incidence andseverity

    of pain and nausea and vomiting (PONV) after ambula-

    tory surgery. Seventy-eight ASA physical status I-III pa-

    tients scheduled for hemorrhoidectomy or hallux valgus

    correction were studied using a randomized, double-

    blind, placebo-controlled protocol. One group received

    12 mg of betametbasone lM 30 min before the start of sur-

    gery (Group B), whereas the placebo group (Group I) re-

    ceived saline. General anesthesia was induced with

    propofol and fentanyl and maintained with isoflurane in

    both groups. Pain (measured using a visual analog scale,

    verbal score, and analgesic requirements), PONV, and

    other side effects were evaluated postoperatively. Pa-

    tients in Group B experienced significantly less postoper-

    ative pain, less PONV, and better pat ient satisfaction dur-

    ing the first 24 h after surgery. ln conclusion, a single dose

    of betametbasone (12 mg) seemed to produce analgesic

    and antiemetic effects after day-case surgery. Implica-

    tions:

    ln aplacebo-controlled tudy, the useof corticoste-

    roid prophylaxis (betamethasone)roduceda significant

    reduction n both postoperativepainand nausean outpa-

    tientswho received he corticosteroid njectionbefoream-

    bulatory foot or hemorrhoidoperations.

    (Anesth Analg 1998;87:319-23)

    rostaglandins are important mediators of pain.

    P

    y inhibiting the phospholipase enzyme, the

    glucocorticoids block both the cyclooxygenase

    and the lipooxygenase pathway in the inflammatory

    chain reaction. Thus, these compounds may be effec-

    tive in reducing pain and may have a different side-

    effect profile than the nonsteroidal antiinflammatory

    drugs (NSAIDs).

    Corticosteroids have been studied for postoperative

    pain relief in oral surgery (l-3). Skjelbred and L&ken

    (1) found that 9 mg of betamethasone after dental

    surgery alleviated postoperative pain and swelling

    effectively. Although analgesic effects have also been

    reported after general surgery (4), orthopedic surgery

    (5), or back surgery (6,7), others studies have not cor-

    roborated these reports (8-11).

    The aim of the present study was to evaluate the

    postoperative effects of betamethasone 12 mg IM after

    proctologic or orthopedic ambulatory surgery.

    Financial upportwasprovidedasa research rantbeforestudy

    start from Shering-Plough, orway, the distributor of Celeston

    Chronodosebetamethasone).

    Accepted or publicationMay 5, 1998.

    Addresscorrespondencend reprint requestso Vidar Aasboe,

    MD, Department f Anesthesia, estfoldCentralHospital,N-1603

    Fredrikstad, orway.

    01998 by the International Anesthesia Research Society

    0003-2999/98/$5.00

    Methods

    The study was approved by our regional ethics com-

    mittee and was performed according to the Helsinki II

    Declaration. Eighty patients scheduled for ambulatory

    surgery involving either hallux valgus (Mitchells op-

    eration) or hemorrhoids (Milligans operation) were

    included after giving their informed consent. The in-

    clusion criteria included age >18 yr, ASA physical

    status I-III, and no corticosteroids during last week or

    NSAIDs during the 2 days before the operation. The

    exclusion criteria included known allergy or contrain-

    dications to any of the test drugs or pregnancy.

    All the patients were instructed in the use of the

    visual analog scale (VAS) for pain, with an unmarked

    line of 100 mm from 0 = no pain to 100 = most

    extreme pain, before surgery. The patients were ran-

    domly assigned to double-blind administration, from

    coded ampules, of 2 mL of the test drug IM 30 min

    before the start of surgery. Group B received beta-

    methasone 12 mg, containing 50 betamethasone di-

    sodiumphosphate with fast onset and 50 betametha-

    sone acetate with slower onset and longer duration.

    Group I received 2 mL of saline in lipid solution,

    which was prepared by the hospital pharmacy to ap-

    pear identical to the test drug.

    The patients received midazolam 0.04 mg/kg IV

    on arrival in the operating room. General anesthesia

    was induced with fentanyl 2 pg/kg and propofol

    Anesth Analg 1998;87:319-23 319

  • 7/23/2019 Betamethasone Reduces Postoperative Pain and.15

    2/5

    320

    AMBULATORY ANESTHESIA AASBOE ET AL.

    EFFEC T OF BETAMETHASO NE ON PONV

    ANESTH ANALG

    1998;87:319-23

    2.0 mg/kg IV. Anesthesia was maintained with isoflu-

    rane 0.5 -1.5 and nitrous oxide 66 in oxygen

    without opioid supplementation. Isoflurane was ad-

    justed to maintain the mean arterial pressure and

    heart rate within 30 of preoperative values. The

    patients breathed spontaneously through a laryngeal

    mask airway and were monitored with end-tidal cap-

    nography and gas monitor, pulse oximeter, electrocar-

    diogram, and noninvasive blood pressure device.

    The postoperative pain was evaluated 0, 1,2,3, and

    4 h after surgery using the loo-mm VAS, a verbal

    score of O-3 (0 = no pain, 1 = slight pain, 2 = mod-

    erate pain, 3 = severe pain), and opioid requirements

    (meperidine 10 mg IV when requested or VAS

    >40 mm). Side effects such as postoperative nausea

    and vomiting (PONV), dyspepsia, bleeding, and seda-

    tion were subjectively evaluated. Any episode of

    PONV (including retching) during the preceding hour

    was noted. Metoclopramide 10 mg was given IV for

    PONV when requested by the patient. After the first 4

    postoperative hours, the patients received acetamino-

    phen 500 mg + codeine 30 mg tablets for pain when

    needed. Times to eligibility for discharge were evalu-

    ated regularly according to the criteria of Korttila (12),

    and the actual discharge time was noted.

    The day after surgery, the patients were contacted

    by telephone and asked to evaluate their pain using

    the verbal score during rest, ambulation, sitting in a

    chair (for hemorrhoid patients), and leg movement

    (for hallux valgus patients). They were also asked

    about analgesic consumption and the occurrence of

    PONV. The patients were asked to evaluate their over-

    all experience during the postoperative period as ei-

    ther unacceptable, adequate, or good. A similar tele-

    phone interview was performed 7 days after the

    surgery.

    To detect a reduction in moderate to severe postop-

    erative pain from 60 to 30 with a power of 0.8 and

    a P value of 0.05, 80 patients were studied. The data

    were analyzed by using Students t-test for parametric

    data and the Mann-Whitney U-test or 2 test for non-

    parametric data, with a P value ~0.05 regarded as

    significant.

    Results

    Eighty patients were included in the study. Two pa-

    tients were excluded because the surgical procedure

    was changed after inclusion. There were no significant

    differences between the two groups in demographic

    data (Table 1) or vital signs in the perioperative pe-

    riod. The postoperative data for the two groups dis-

    tributed as a function of the surgical procedure are

    shown in Table 2. Because data for hallux valgus

    correction and hemorrhoid extirpation were similar,

    these data were pooled. On admission to the recovery

    Table 1. Demographic Data

    Group P Group B

    (placebo, = 40) (betamethasone,= 38)

    Age (ye=4

    45 + 14 44 ? 13

    Height (cm) 168 6.8 169 c 13

    Weight (kg) 64? 11 65 ? 10

    Male/female 5 /35 10 28

    Hemorrhoids/ 18 22

    24 /14

    hallux valgus

    Duration of surgery

    e-4

    Hemorrhoids

    16? 6 15+ 6

    Hallux valgus 25-c5 26 ? 9

    Propofoldose mg)

    135+26

    135 2 27

    room, 58 of the patients in Group I complained of

    moderate or severe pain, significantly more than in

    Group B (32 ). In the 4-h postoperative observation

    period, significantly more pain was reported by the

    patients in Group P 3 and 4 h postoperatively (Fig. 1).

    In the 4-h postoperative observation period, there was

    no significant difference in PONV or in the need for

    antiemetics between the groups, with 11 patients

    (28 ) in Group I receiving metoclopramide versus 7

    (18 ) in Group B. There were no differences in other

    side effects, time to eligibility for discharge, or actual

    discharge time between the two groups.

    In the 5- to 24-h postoperative observation period,

    significantly more PONV and pain occurred in the

    placebo group. Only 4 (11 ) patients experienced any

    nausea or vomiting in Group B, versus 15 (38 ) in

    Group P (P < 0.01). Only nine patients in Group B

    (24 ) experienced moderate or severe pain, compared

    with 25 (63 ) in Group P (P < 0.001) (Fig. 2). In the

    patients undergoing hemorrhoidectomy, there was

    also significantly more pain in Group P while sitting

    (P < 0.05). In the hallux valgus patients, pain was

    significantly more severe in Group P during leg move-

    ment (P < 0.05).

    When the patients were asked for overall postoper-

    ative satisfaction at 24 h, significantly more patients

    had a good experience in Group B (Table 3) (P